PSMD13, also known as the 26S proteasome non-ATPase regulatory subunit 13, is a crucial component of the proteasome, a complex protein machinery responsible for the regulated degradation of ubiquitinated proteins. This system plays a key role in various cellular processes, including the cell cycle, apoptosis, DNA repair, and response to oxidative stress by ensuring that damaged, faulty, or excess proteins are quickly and efficiently broken down and recycled. PSMD13 specifically contributes to the structural integrity and functional regulation of the 19S regulatory particle of the proteasome. This regulatory particle acts as the gateway for proteins destined for degradation in the 20S core particle. It recognizes ubiquitinated proteins, unfolds them, and translocates them into the core particle where they are degraded into peptides. This function is essential for maintaining protein homeostasis and allowing the cell to adapt to metabolic or environmental changes.
The activation of PSMD13 is intricately linked to its role within the dynamic assembly of the proteasome. Activation typically involves the orchestration of several regulatory mechanisms that ensure PSMD13 is available and functional when needed. One key aspect of PSMD13 activation involves its incorporation into the proteasome complex, which is regulated at both the transcriptional and post-translational levels. On a transcriptional level, the expression of PSMD13 can be upregulated in response to signals that indicate increased cellular stress or a heightened need for protein turnover, such as during cell cycle transitions or in response to oxidative stress. Post-translationally, PSMD13 may be activated through modifications like phosphorylation, which can affect its interaction with other subunits of the proteasome and enhance its role in protein degradation. Additionally, the proper functioning of PSMD13 often requires direct interactions with other proteasomal subunits and co-factors, which can facilitate its correct positioning and stability within the 19S regulatory particle. These mechanisms ensure that PSMD13 is not only produced in adequate amounts but is also functionally competent to contribute effectively to the proteasome's role in cellular regulation. Understanding the activation of PSMD13 provides valuable insights into the adaptive capacity of cellular proteolytic systems, highlighting the complexity of cellular mechanisms designed to maintain internal stability and respond to external challenges.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Inhibitors of ubiquitin-activating enzyme E1, disrupting ubiquitin-mediated processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Altering gene expression patterns, affecting pathways involving PSMD13. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibiting NF-κB signaling, potentially influencing PSMD13-regulated gene expression. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Inducing oxidative stress, leading to alterations in cellular signaling pathways. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activation of AMPK, influencing cellular energy homeostasis and signaling pathways. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Activation of Nrf2, modulating the cellular antioxidant response, potentially affecting PSMD13. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibition of the PI3K/Akt/mTOR pathway, indirectly impacting PSMD13-related processes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
DNA damage responses leading to intricate signaling networks, with potential PSMD13 involvement. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Influencing intracellular calcium levels, potentially impacting PSMD13-related processes. | ||||||